BAP1 maintains HIF-dependent interferon beta induction to suppress tumor growth in clear cell renal cell carcinoma

Lauren E Langbein1, Rayan El Hajjar1, Shen He1

  • 1Department of Pathology, Anatomy, & Cell Biology, Thomas Jefferson University, Philadelphia, PA, United States.

Cancer Letters
|August 22, 2022
PubMed

Insights

Loss of BRCA1-associated protein 1 (BAP1) in clear cell renal cell carcinoma (ccRCC) impairs type I interferon signaling. Reactivating this pathway offers a potential therapeutic strategy for ccRCC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • BRCA1-associated protein 1 (BAP1) is frequently mutated in clear cell renal cell carcinoma (ccRCC), correlating with poor outcomes.
  • The tumor suppressor functions of BAP1 in ccRCC pathogenesis are not fully understood.
  • Hypoxia-inducible factor 2α (HIF2α) and BAP1 were previously shown to activate interferon-stimulated gene factor 3 (ISGF3), a tumor suppressor in ccRCC models.

Purpose of the Study:

  • To elucidate the mechanisms by which hypoxia-inducible factors (HIF) and BAP1 regulate ISGF3 activity in ccRCC.
  • To investigate the role of type I interferon signaling in BAP1-deficient ccRCC.

Main Methods:

  • Utilized ccRCC cell lines and xenograft models.
  • Investigated gene expression of interferon beta (IFN-β) and stimulator of interferon genes (STING).
  • Assessed ISGF3 activation through overexpression and STING agonist treatment.

Main Results:

  • Loss of the von Hippel-Lindau tumor suppressor (VHL) in ccRCC cells induced IFN-β expression in a HIF2α-dependent manner.
  • IFN-β was essential for ISGF3 activation and inhibited tumor growth in xenografts.
  • BAP1 positively regulated IFN-β and STING expression, thereby enhancing ISGF3 activity.
  • Restoring ISGF3 activity via overexpression or STING agonism suppressed BAP1-deficient tumor growth.

Conclusions:

  • BAP1 loss diminishes type I interferon signaling in ccRCC.
  • Reactivation of the type I interferon pathway presents a promising therapeutic avenue for ccRCC treatment.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K